(en) Barbara Mühlemann, Terry C. Jones, Peter de Barros Damgaard, Morten E. Allentoft, Irina Shevnina et al., « Ancient hepatitis B viruses from the Bronze Age to
the Medieval period », Nature, vol. 557, , p. 418-423 (DOI10.1038/s41586-018-0097-z).
(en) Margaret Littlejohn, Stephen Locarnini et Lilly Yuen, « Origins and evolution of hepatitis B virus and hepatitis D virus », Cold Spring Harbor Perspectives in Medicine, vol. 6, , article no a021360 (DOI10.1101/cshperspect.a021360).
(en) A. Kramvis, « Genotypes and genetic variability of hepatitis B virus », Intervirology, vol. 57, , p. 141-150 (DOI10.1159/000360947).
Alter MJ, « Epidemiology and prevention of hepatitis B », Semin. Liver Dis., vol. 23, no 1, , p. 39-46 (PMID12616449, DOI10.1055/s-2003-37583)
Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG, « HBV pathogenesis in animal models: recent advances on the role of platelets », J. Hepatol., vol. 46, no 4, , p. 719–26 (PMID17316876, DOI10.1016/j.jhep.2007.01.007)
Chu CM, Liaw YF, « Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B », Gastroenterology, vol. 133, no 5, , p. 1458–65 (PMID17935720, DOI10.1053/j.gastro.2007.08.039)
Zoulim F, « New nucleic acid diagnostic tests in viral hepatitis », Semin. Liver Dis., vol. 26, no 4, , p. 309–17 (PMID17051445, DOI10.1055/s-2006-951602)
Hollinger FB, Lau DT, « Hepatitis B: the pathway to recovery through treatment », Gastroenterol. Clin. North Am., vol. 35, no 4, , p. 895–931 (PMID17129820, DOI10.1016/j.gtc.2006.10.002)
Hui CK, Lau GK, « Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B », Expert review of anti-infective therapy, vol. 3, no 4, , p. 495–504 (PMID16107195, DOI10.1586/14787210.3.4.495)
Pungpapong S, Kim WR, Poterucha JJ, « Natural history of hepatitis B virus infection: an update for clinicians », Mayo Clin Proc, vol. 82, no 8, , p. 967–75 (PMID17673066)
Zuckerman AJ, Hepatitis Viruses. In: Baron's Medical Microbiology (Baron S et al, eds.), Univ of Texas Medical Branch, (réimpr. 4th ed.) (présentation en ligne)
Locarnini S, « Molecular virology of hepatitis B virus », Semin. Liver Dis., vol. 24 Suppl 1, , p. 3–10 (PMID15192795, DOI10.1055/s-2004-828672)
Howard CR, « The biology of hepadnaviruses », J. Gen. Virol., vol. 67 ( Pt 7), , p. 1215–35 (PMID3014045)
Kay A, Zoulim F, « Hepatitis B virus genetic variability and evolution », Virus Res., vol. 127, no 2, , p. 164–76 (PMID17383765)
J. Beck et M. Nassal, « Hepatitis B virus replication », World Journal of Gastroenterology, vol. 13, no 1, , p. 48–64 (PMID17206754)
Magnius LO, Norder H, « Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene », Intervirology, vol. 38, nos 1-2, , p. 24–34 (PMID8666521)
Alter HJ, Blumberg BS, « Further studies on a "new" human isoprecipitin system (Australia antigen) », Blood, vol. 27, no 3, , p. 297–309 (PMID5930797)
Dane DS, Cameron CH, Briggs M, « Virus-like particles in serum of patients with Australia-antigen-associated hepatitis », Lancet, vol. 1, no 7649, , p. 695–8 (PMID4190997)
Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P, « Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli », Nature, vol. 281, no 5733, , p. 646–50 (PMID399327)
« Hepatitis B vaccine », Lancet, vol. 2, no 8206, , p. 1229–30 (PMID6108398)
Petersen NJ, Barrett DH, Bond WW, Berquist KR, Favero MS, Bender TR, Maynard JE, « Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages », Appl. Environ. Microbiol., vol. 32, no 4, , p. 572-574 (PMID791124).
Shapiro CN, « Epidemiology of hepatitis B », Pediatr. Infect. Dis. J., vol. 12, no 5, , p. 433–7 (PMID8392167).
Alter MJ, « Epidemiology and prevention of hepatitis B », Semin. Liver Dis., vol. 23, no 1, , p. 39-46 (PMID12616449, DOI10.1055/s-2003-37583)
Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG, « HBV pathogenesis in animal models: recent advances on the role of platelets », J. Hepatol., vol. 46, no 4, , p. 719–26 (PMID17316876, DOI10.1016/j.jhep.2007.01.007)
Iannacone M, Sitia G, Isogawa M, Marchese P, Castro M, Lowenstein P, Chisari F, Ruggeri Z, Guidotti L, « Platelets mediate cytotoxic T lymphocyte-induced liver damage », Nat. Med., vol. 11, no 11, , p. 1167-1169 (PMID16258538, lire en ligne)
Oliveri F, Brunetto MR, Actis GC, Bonino F, « Pathobiology of chronic hepatitis virus infection and hepatocellular carcinoma (HCC) », The Italian journal of gastroenterology, vol. 23, no 8, , p. 498–502 (PMID1661197)
Bonino F, Chiaberge E, Maran E, Piantino P, « Serological markers of HBV infectivity », Ann. Ist. Super. Sanita, vol. 24, no 2, , p. 217–23 (PMID3331068)
Chu CM, Liaw YF, « Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B », Gastroenterology, vol. 133, no 5, , p. 1458–65 (PMID17935720, DOI10.1053/j.gastro.2007.08.039)
Zoulim F, « New nucleic acid diagnostic tests in viral hepatitis », Semin. Liver Dis., vol. 26, no 4, , p. 309–17 (PMID17051445, DOI10.1055/s-2006-951602)
Hollinger FB, Lau DT, « Hepatitis B: the pathway to recovery through treatment », Gastroenterol. Clin. North Am., vol. 35, no 4, , p. 895–931 (PMID17129820, DOI10.1016/j.gtc.2006.10.002)
Lai CL, Yuen MF, « The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points », Ann. Intern. Med., vol. 147, no 1, , p. 58–61 (PMID17606962)
Hui CK, Lau GK, « Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B », Expert review of anti-infective therapy, vol. 3, no 4, , p. 495–504 (PMID16107195, DOI10.1586/14787210.3.4.495)
osap.org
Redd JT, Baumbach J, Kohn W, et al., « Patient-to-patient transmission of hepatitis B virus associated with oral surgery », J Infect Dis, vol. 195, no 9, , p. 1311–4 (lire en ligne [PDF])
